インドの幹細胞市場機会

RNCOSが発行した調査報告書(RNCS51104)
◆英語タイトル:Opportunities in Indian Stem Cell Market
◆商品コード:RNCS51104
◆発行会社(リサーチ会社):RNCOS
◆発行日:2015年10月
◆ページ数:60
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:インド
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様利用)USD700 ⇒換算¥79,100見積依頼/購入/質問フォーム
Multi-UserUSD1,100 ⇒換算¥124,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はRNCOS社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。RNCOS社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Realizing the potential of stem cells, the stem cell industry has been gaining ground in India over the past few years. Although, the market is still in a very nascent stage as compared to developed economies, like the US and Europe, it is expected to grow rapidly in the coming years. The stem cell market in India is mainly concentrated with companies offering stem cell banking facilities, and a very few players are involved in the commercialization of stem cell based products.

With intensive R&D efforts and increasing investments from both government and private organizations in stem cell research, stem cell therapy is expected to emerge as the new elixir for the treatment of various degenerative diseases. Moreover, the liberal regulations governing the stem cell market in India can be an important factor for attracting an increasing number of organizations to invest, create and commercialize promising technologies, thus driving further growth in the market.

According to our research report, “Opportunities in Indian Stem Cell Market”, India has the potential to become one of the fastest growing stem cell markets in the world, mainly owing to Stem Cell Banking segment, which is anticipated to grow at a CAGR of around 50% during 2014-2020. With a large number of clinical trials underway, the field of stem cell biology is likely to move towards translational research, and eventually to clinical practice in India.

Our report has been authored to evaluate the Indian Stem Cell Market in terms of Stem Cell Banking and Stem Cell Research, so as to identify the market potential and future growth opportunities. It provides extensive research and analysis of the drivers responsible for the growth of this market, as well as the challenges being faced by the industry.

The report also provides an insight into the recent developments that have taken place in the industry. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities and potentials in the nascent Indian stem cell market.

【レポートの目次】

1. Analyst View
2. Research Methodology
3. Drivers
3.1 Rising Incidences of Chronic Diseases
3.2 Increasing Aging Population
3.3 Government Initiatives Accelerating Market Growth
3.4 Growing Medical Tourism
4. Challenges
4.1 Lack of Awareness
4.2 Lack of Sufficient Regulations
4.3 High Cost of Stem Cell Therapy and Banking
5. Stem Cell Products
5.1 Embryonic Stem Cells
5.2 Adult Stem Cells
5.3 Umbilical Cord Stem Cells
5.4 Dental Stem Cells
6. Stem Cell Applications
6.1 Regenerative Medicine
6.2 Drug Development
7. Stem Cell Industry Outlook
7.1 Stem Cell Banking
7.2 Stem Cell Research
8. Government Regulations
9. Recent Developments
10. Competitive Landscape
10.1 Reliance Life Sciences
10.2 LifeCell International Private Limited
10.3 Cryobanks International India Private Limited
10.4 Cryo-Save (India) Private Limited
10.5 Cordlife India
10.6 StemCyte India Therapeutics Private Limited
10.7 ReeLabs Private Limited
10.8 Stempeutics Research Private Limited
10.9 Regenerative Medical Services Private Limited
10.10 International Stemcell Services Limited

List of Figures:

Figure 3-1: India – Relative Burden of Chronic Conditions (2015)
Figure 3-2: India – Population Aged 60 and Above (Million), 2014 & 2050
Figure 3-3: India – Medical Tourism Market (Billion US$), 2014-2020
Figure 7-1: India – Stem Cell Banking Market (Million US$), 2014-2020

List of Tables:

Table 7-1: Stem Cell Clinical Trials Registered in Clinical Trials Registry – India (CTRI)
Table 10-1: Reliance Life Sciences – Stem Cell Products Offered
Table 10-2: Reliance Life Sciences – Programs Offered Under Cord Blood Repository Services
Table 10-3: LifeCell International Pvt. Ltd. – Umbilical Cord Stem Cell Banking Plans and Price
Table 10-4: Cryo-Save (India) Pvt. Ltd. – Umbilical Cord Blood Banking Price
Table 10-5: Cordlife India – Umbilical Cord Stem Cell Banking Plans and Price (21 Years Storage)
Table 10-6: Regenerative Medical Services Pvt. Ltd. – Stem Cell Therapy Products



【レポートのキーワード】

幹細胞、インド

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ インドの幹細胞市場機会(Opportunities in Indian Stem Cell Market)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆